Story

Cardinal Health Stock Rises on Long-Term CVS Contract Extension, Reaffirmed Guidance

ENTHMSVIIDZHZH-TWJAKOHI
Oct 1, 20261 min read
Cardinal Health Stock Rises on Long-Term CVS Contract Extension, Reaffirmed Guidance

Summary

Shares of the healthcare distributor climbed after it secured its pharmaceutical distribution agreement with CVS Health through 2032 and confirmed its fiscal 2027 earnings forecast.

Text size
Background

Cardinal Health (NYSE:CAH) shares climbed 3.8% in afternoon trading after the company announced a long-term extension of its pharmaceutical distribution agreement with key customer CVS Health. The company also reaffirmed its fiscal 2027 earnings forecast, removing a significant source of investor uncertainty and boosting confidence in its long-term stability.

Key Agreement Secured

Cardinal Health announced it has entered into a binding letter of intent to extend its pharmaceutical distribution agreement with CVS Health through June 30, 2032. The deal maintains the current scope of distribution services, solidifying a critical, long-term revenue stream for the company.

CVS Health represents one of Cardinal Health’s most significant client relationships. Securing the contract for the remainder of the decade provides enhanced revenue visibility and stability for the company's core pharmaceutical segment.

Guidance and Investor Confidence

In conjunction with the contract news, Cardinal Health reaffirmed its fiscal year 2027 guidance for non-GAAP earnings per share of $12.40 to $12.60. This target represents a projected growth rate of 13% to 15%, signaling to investors that management's long-term business outlook remains intact.

Sample IUX Markets – In-articleAd

Adding to the day's catalysts, the company noted that the stock's ex-dividend date for its quarterly cash dividend of approximately $0.516 per share was also today. Cardinal Health confirmed it will release its first-quarter fiscal 2027 financial results on November 5.

Market Reaction

The stock's strong performance significantly outpaced the broader market, which saw only modest gains. The S&P 500 was up approximately 0.4%, indicating that Cardinal Health's rally was driven by company-specific news rather than a wider market trend.

Investors reacted positively to the combination of the secured contract and the confirmed financial targets, which together address key questions about the company's future revenue and profitability.

Read next

More on Stocks
Back to latest news

LATEST